medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 2

<< Back Next >>

Med Int Mex 2020; 36 (2)

Clinical characterization of dengue, chikungunya and Zika during 2016 in Veracruz, Mexico

Del Carpio-Orantes L, Moreno-Aldama NP, Sánchez-Díaz JS
Full text How to cite this article

Language: Spanish
References: 11
Page: 147-152
PDF size: 183.41 Kb.


Key words:

Dengue, Zika, Chikungunya.

ABSTRACT

Background: With the arrival of chikungunya and Zika arboviruses, the clinical diagnosis between these and dengue becomes even more complicated as they share similarities in their clinical pictures.
Objective: To characterize the population affected and to integrate clinical triads with the most frequent signs and symptoms in this study population, in order to discern between one and other arbovirosis.
Material and Method: A descriptive and comparative study of cases of vectorborne arbovirosis presented in the Veracruz North delegation during 2016, classifying them according to the operational definitions of suspect cases of dengue, Zika and chikungunya.
Results: A total of 10,327 cases of arbovirosis were recorded, of which 5388 cases met the operational definition of non-serious dengue (52.2%), 3529 cases of Zika (34.1%) and 1410 cases of chikungunya (13.6%). The main symptoms and signs presented in cases of dengue were: fever, headache, arthralgia, rash and nausea/ vomiting; for Zika cases: exanthema, adenomegalias, headache, arthralgias and conjunctivitis; for the cases of chikungunya: rash, fever, arthralgia, headache and nausea/vomiting. Due to its high incidence, the main symptoms were grouped into triads that have particularities, the dengue triad was composed of fever, headache defiand arthralgias; the Zika triad by exanthema, adenomegalias and arthralgias; and that of Chikungunya by rash, fever and arthritis.
Conclusion: It was possible to characterize each case according to the definitions of a suspect case and triads were integrated with particularities that can be used as a clinical diagnostic aid.


REFERENCES

  1. Del Carpio-Orantes L. Virosis emergentes en México. Revista Médica del Instituto Mexicano del Seguro Social 2013;51(1):8-11.

  2. Del Carpio-Orantes L. Arbovirus emergentes en México: chikunguña y zika. Rev Med Inst Mex Seguro Soc 2016;54(3):278-279.

  3. Del Carpio-Orantes L. Zika, a neurotropic virus? Rev Med Inst Mex Seguro Soc. 2016;54(4):540-3.

  4. Del Carpio Orantes L, Juárez Rangel FJ, García-Méndez S. Incidencia de síndrome de Guillain Barré durante la oleada de zika del 2016 en un hospital de segundo nivel. Neurología 09/2017; DOI:10.1016/j.nrl.2017.07.019.

  5. Del Carpio-Orantes L, et al. Síndrome de Guillain-Barré asociado a zika; análisis de la cohorte delegacional en la región Veracruz norte durante 2016-2017. Neurología 2018. https://doi.org/10.1016/j.nrl.2018.05.002.

  6. Del Carpio Orantes L. Síndrome de Guillain-Barré asociado a zika, experiencia americana. Estudio bibliométrico. Neurología 2018. https://doi.org/10.1016/j.nrl.2018.05.001.

  7. Del Carpio-Orantes L, Pola-Ramírez MR, García-Méndez S, Mata-Miranda MP, Perfecto Arroyo MA, Solís-Sánchez I, et al. Agentes causales más frecuentes del síndrome de Guillain Barré en un hospital general mexicano. Rev Neurol 2018;67(6):203-209.

  8. Lineamientos Estandarizados para la Vigilancia Epidemiológica y Diagnóstico por Laboratorio de Infección por Virus Zika. Dirección General de Epidemiología, México, 2017.

  9. Instrumento para el diagnóstico y la atención a pacientes con sospecha de arbovirosis. Washington, DC: OPS; 2016.

  10. Del Carpio-Orantes L. Dengue for apparatus and systems. MEDtube Science 2015 Sep 3(3):21-24.

  11. Del Carpio-Orantes L. Zika ¿Zika, enfermedad afebril? Rev Med Inst Mex Seguro Soc 2018;56(3):305-8.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2020;36